Select your branch

Daniel Moreno is the Head of Marketing and Communication at the Innovation Forum. He was also the President and founder of Innovation Forum Manchester.

Daniel is a Postdoctoral Research Associate in Manchester Metropolitan University, where he investigates the effects of Ibrutinib, a Bruton's Tyrosine Kinase inhibitor, on platelet and endothelial cells in the context of chronic lymphocytic leukaemia.

Interested in entrepreneurship through leadership and innovation, Daniel has many years of experience working with stakeholders and leading international teams: he was Vice-chairman of the Young European Biotechnology Network, where he was also Chief Communication Officer and an Executive Board member. He has participated in the organisation of many scientific and outreach meetings in the UK, Germany, Switzerland and Spain.

Daniel is also a co-opted committee member of the British Society for Cardiovascular Research, where he is working in stablishing an online presence for the society.